COMMUNIQUÉS West-GlobeNewswire

DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social

27/08/2018 - 18:31

Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]

Vitalhub Reports Second Straight Quarter of Positive Adjusted EBITDA

27/08/2018 - 18:29

TORONTO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]

Landmarks Around the World to “Go Teal” on November 8th for AFA’s “Light the World in Teal” Alzheimer’s Awareness Campaign

27/08/2018 - 18:08

One World Trade Center, Madison Square Garden, LAX Airport, Country Music Hall of Fame and Wrigley Building Among the Approximately 200 Landmarks “Going Teal” to Raise Alzheimer’s Awareness NEW YORK, Aug. 27, 2018 ( [...]

Adamis Pharmaceuticals Provides Business Update

27/08/2018 - 18:02

SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided a business update. Dr. Dennis J. Carlo, President and Chief Executive Officer of Adamis Pharmaceuticals, said [...]

Ossur Hf : Transactions in relation to share buyback program

27/08/2018 - 18:01

Announcement no. 52/2018 27 August 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]

Sanofi : Disclosure of trading in own shares

27/08/2018 - 18:01

Attachment Reporting EN.pdf

Sanofi : Déclaration des transactions sur actions propres

27/08/2018 - 18:01

Pièce jointe Reporting FR.pdf

CORRECTING and REPLACING -- Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conference

27/08/2018 - 18:00

WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- In a release issued earlier today by Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) please note that the upcoming investor conference details have been updated. The [...]

MPI - FDA approves OVs IDE and IND for ovarian cancer with its PARP inhibitor and DRP

27/08/2018 - 17:01

Hoersholm, Denmark, August 27, 2018 - Medical Prognosis Institute A/S and Oncology Venture AB (OV:ST) ("OV" or the "Company") and Oncology Venture US Inc today announced that the US Food and Drug Administration (FDA) [...]

GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions

27/08/2018 - 16:33

Villepinte (France), le 27 août 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur la [...]

Misonix to Report Fiscal 2018 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 5

27/08/2018 - 16:00

FARMINGDALE, N.Y., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]

Biohit Oyj: Managers' Transactions

27/08/2018 - 15:50

BIOHIT OYJ MANAGERS’ TRANSACTIONS 27 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Semi Korpela Position: Chief Executive Officer Issuer: Biohit Oyj LEI: [...]

Biohit Oyj: Managers' Transactions

27/08/2018 - 15:15

BIOHIT OYJ MANAGERS’ TRANSACTIONS 24 AUGUST 2018 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior Management Issuer: Biohit Oyj LEI: [...]

Sienna Biopharmaceuticals Announces Results from First-in-Human Study of SNA-125 in Psoriasis and Continued Progression to Phase 2

27/08/2018 - 15:05

-- Phase 1/2 study data of SNA-125 in atopic dermatitis on track to be released in fourth quarter of 2018 -- SNA-125 Phase 2 studies expected to begin in second half of 2019 WESTLAKE VILLAGE, Calif., Aug. 27, 2018 ( [...]

Obalon Therapeutics Announces Closing of $10 Million Private Placement

27/08/2018 - 15:02

SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]

Delcath Announces Acceptance of Abstract for Poster Presentation at CIRSE 2018

27/08/2018 - 15:00

NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces an abstract from a [...]

Naturally Splendid Increases Vertical Integration and Expands International Footprint -- CFN Media

27/08/2018 - 15:00

SEATTLE, Aug. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Lexington Announces Non-Brokered Private Placement

27/08/2018 - 15:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, Aug. 27, 2018 (GLOBE NEWSWIRE [...]

AXIM® Biotechnologies Enters Canadian Market Through New Exclusive Distribution and License Agreement With Revive Therapeutics

27/08/2018 - 15:00

AXIM Partners with REVIVE to Begin Selling Its Leading Cannabidiol-Containing Nutraceutical Product in Canada NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM® Biotech or the “Company” ) ( [...]